Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 4, Pages 1173
Publisher
MDPI AG
Online
2018-04-13
DOI
10.3390/ijms19041173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor necrosis factor α in the onset and progression of leukemia
- (2017) Xiaoxi Zhou et al. EXPERIMENTAL HEMATOLOGY
- Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells
- (2017) Lan Deng et al. Oncology Letters
- Molecular targets of luteolin in cancer
- (2016) Muobarak J. Tuorkey EUROPEAN JOURNAL OF CANCER PREVENTION
- How I treat refractory and early relapsed acute myeloid leukemia
- (2015) F. Thol et al. BLOOD
- Up-Regulation of miR-34a Expression in Response to the Luteolin-Induced Neurite Outgrowth of PC12 Cells
- (2015) Pei-Yi Chen et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
- (2015) Jacqueline E. Noll et al. Journal of Hematology & Oncology
- Small molecule Mcl-1 inhibitors for the treatment of cancer
- (2015) Johannes Belmar et al. PHARMACOLOGY & THERAPEUTICS
- Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review
- (2014) Ashok Kumar Pandurangan et al. Asian Pacific Journal of Cancer Prevention
- Prostate Cancer Cell Response to Paclitaxel Is Affected by Abnormally Expressed Securin PTTG1
- (2014) C. Castilla et al. MOLECULAR CANCER THERAPEUTICS
- Flavonoids as receptor tyrosine kinase FLT3 inhibitors
- (2013) Young-Won Chin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Acute myeloid leukemia associated with FGFR1 abnormalities
- (2013) Hyeyoung Lee et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Down-Regulation of the Oncogene PTTG1 via the KLF6 Tumor Suppressor during Induction of Myeloid Differentiation
- (2013) Pei-Yi Chen et al. PLoS One
- Natural Products for Cancer-Targeted Therapy: Citrus Flavonoids as Potent Chemopreventive Agents
- (2012) Edy Meiyanto et al. Asian Pacific Journal of Cancer Prevention
- Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125
- (2012) Simona Caporali et al. BIOCHEMICAL PHARMACOLOGY
- Role of p53 family members p73 and p63 in human hematological malignancies
- (2012) Evguenia M. Alexandrova et al. LEUKEMIA & LYMPHOMA
- Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review)
- (2012) GUANHUA SONG et al. ONCOLOGY REPORTS
- Securin Enhances the Anti-Cancer Effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in Human Colorectal Cancer Cells
- (2012) Ho-Hsing Tseng et al. PLoS One
- Luteolin Induces microRNA-132 Expression and Modulates Neurite Outgrowth in PC12 Cells
- (2012) Lian-Fang Lin et al. PLoS One
- Role of p63 in cancer development
- (2011) Vincenzo Graziano et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Anti-carcinogenic Effects of the Flavonoid Luteolin
- (2011) Günter Seelinger et al. MOLECULES
- Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling
- (2011) Y C Liao et al. ONCOGENE
- Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway
- (2010) Chye-Sun Ong et al. CANCER LETTERS
- Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells
- (2010) Samir Attoub et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pituitary tumor-transforming gene and its binding factor in endocrine cancer
- (2010) Vicki E. Smith et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Neurotrophic and Cytoprotective Action of Luteolin in PC12 Cells through ERK-Dependent Induction of Nrf2-Driven HO-1 Expression
- (2010) Chia-Wei Lin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
- (2010) M Wunderlich et al. LEUKEMIA
- Differentiation-associated alteration in sensitivity to apoptosis induced by (-)-epigallocatechin-3-O-gallate in HL-60 cells
- (2009) Norihisa Okada et al. BIOMEDICAL RESEARCH-TOKYO
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Transcriptional targets for pituitary tumor-transforming gene-1
- (2009) Yunguang Tong et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Distribution and Biological Activities of the Flavonoid Luteolin
- (2009) Miguel Lopez-Lazaro MINI-REVIEWS IN MEDICINAL CHEMISTRY
- New agents in acute myeloid leukemia: Beyond cytarabine and anthracyclines
- (2009) Amir T. Fathi et al. Current Oncology Reports
- Chromosomal translocations: revisited yet again
- (2008) J. D. Rowley BLOOD
- WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis
- (2008) Y Li et al. CELL DEATH AND DIFFERENTIATION
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- (2008) Yong Lin et al. CURRENT CANCER DRUG TARGETS
- Cell cycle control of pituitary development and disease
- (2008) Victor Quereda et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started